Seminars in Thrombosis and Hemostasis

Thieme Medical Publishers (Germany)

Evaluation status available after sign-in

About the journal

Seminars in Thrombosis and Hemostasis is a journal published by Thieme Medical Publishers (Germany) in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Thieme Medical Publishers (Germany)
ISSN
0094-6176 · 1098-9064
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 1975-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4461

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

136

i10-index

2675

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
49%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
0431155
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Blood Coagulation and Thrombosis Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Platelet Disorders and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
Show all subjects (75)
  • Platelet Disorders and Treatments
  • Blood properties and coagulation
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Complement system in diseases
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Blood properties and coagulation
  • Blood properties and coagulation
  • Blood transfusion and management
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Atrial Fibrillation Management and Outcomes
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Protease and Inhibitor Mechanisms
  • Protease and Inhibitor Mechanisms
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Protease and Inhibitor Mechanisms
  • Systemic Lupus Erythematosus Research
  • Clinical Laboratory Practices and Quality Control
  • Blood groups and transfusion
  • Systemic Lupus Erythematosus Research
  • Blood groups and transfusion
  • Systemic Lupus Erythematosus Research
  • Complement system in diseases
  • Complement system in diseases
  • Acute Myocardial Infarction Research
  • Acute Myocardial Infarction Research
  • Acute Ischemic Stroke Management
  • Acute Ischemic Stroke Management
  • Acute Ischemic Stroke Management
  • Cerebral Venous Sinus Thrombosis
  • Pregnancy and preeclampsia studies
  • Blood disorders and treatments
  • Blood disorders and treatments
  • Proteoglycans and glycosaminoglycans research
  • COVID-19 Clinical Research Studies
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Pregnancy and preeclampsia studies
  • Pregnancy and preeclampsia studies
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Proteoglycans and glycosaminoglycans research
  • Hemostasis and retained surgical items
  • Proteoglycans and glycosaminoglycans research
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Acute Myocardial Infarction Research
  • Blood transfusion and management
  • Central Venous Catheters and Hemodialysis
  • Cell Adhesion Molecules Research
  • Inflammatory Biomarkers in Disease Prognosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: